Lipocine Inc (LPCN) — Cash Flow-to-Debt Ratio
Lipocine Inc (LPCN) has a Cash Flow-to-Debt Ratio of -1.46x as of June 2026, meaning its operating cash flow of $-3.03 Million could theoretically repay -1% of its total liabilities ($2.07 Million) in one year. See how financially flexible is Lipocine Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Lipocine Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Lipocine Inc across 15 annual periods. For the full cash flow conversion analysis, see LPCN cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Lipocine Inc (2011–2025)
Year-by-year debt coverage analysis for Lipocine Inc. Check Lipocine Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.86x | $-9.76 Million | $2.53 Million | ▼ -378.3% |
| 2024 | -0.81x | $-1.22 Million | $1.51 Million | ▲ +82.1% |
| 2023 | -4.51x | $-11.87 Million | $2.63 Million | ▲ +28.1% |
| 2022 | -6.27x | $-11.97 Million | $1.91 Million | ▼ -883.0% |
| 2021 | -0.64x | $-4.41 Million | $6.91 Million | ▲ +58.3% |
| 2020 | -1.53x | $-15.30 Million | $10.01 Million | ▼ -75.2% |
| 2019 | -0.87x | $-11.67 Million | $13.37 Million | ▲ +17.5% |
| 2018 | -1.06x | $-12.08 Million | $11.42 Million | ▲ +59.8% |
| 2017 | -2.63x | $-16.70 Million | $6.35 Million | ▲ +80.9% |
| 2016 | -13.79x | $-18.28 Million | $1.33 Million | ▼ -204.5% |
| 2015 | -4.53x | $-15.36 Million | $3.39 Million | ▲ +57.3% |
| 2014 | -10.59x | $-17.30 Million | $1.63 Million | ▼ -58.3% |
| 2013 | -6.69x | $-8.59 Million | $1.28 Million | ▼ -26.6% |
| 2012 | -5.29x | $-62.87K | $11.89K | ▼ -451.1% |
| 2011 | -0.96x | $-7.29K | $7.61K | — |